Lv7
5000 积分 2024-07-23 加入
Laparoscopic Management of Multiple Ureteral Polyps in Children
2个月前
已完结
Chemical composition analysis of Angelica sinensis (Oliv.) Diels and its four processed products by ultra‐high‐performance liquid chromatography coupled with quadrupole‐orbitrap mass spectrometry combining with nontargeted metabolomics
2个月前
已完结
Multiplexed LC‐MS/MS quantification of salivary RNA modifications in periodontitis
2个月前
已完结
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial
3个月前
已完结
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial
3个月前
已完结
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)
3个月前
已完结
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
3个月前
已完结
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
3个月前
已完结
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
3个月前
已完结
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
3个月前
已完结
皖公网安备34019202002308
